Trial Profile
Comparison of Dual-Antiplatelet and Triple-Antiplatelet Preparation Using P2Y12 Assay in Patients With High On-Treatment Platelet Reactivity Undergoing Stent-Assisted Coil Embolization for An Unruptured Intracranial Aneurysm
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2022
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Cilostazol (Primary) ; Clopidogrel (Primary) ; Prasugrel (Primary)
- Indications Embolism and thrombosis
- Focus Therapeutic Use
- 16 Mar 2021 Status changed from recruiting to completed.
- 26 Jul 2020 Protocol amended to include Incidence of thromboembolic complications between 2 arms as primary end point as reported by clinicaltrial.gov record.
- 26 Jul 2020 Planned number of patients changed from 176 to 198.